6-(Furan-2-yl)purine-beta-D-(3'-deoxy-3'-fluoro)riboside manufacturers
|
| | 6-(Furan-2-yl)purine-beta-D-(3'-deoxy-3'-fluoro)riboside Basic information |
| Product Name: | 6-(Furan-2-yl)purine-beta-D-(3'-deoxy-3'-fluoro)riboside | | Synonyms: | 6-(Furan-2-yl)purine-beta-D-(3'-deoxy-3'-fluoro)riboside;(2R,3S,4S,5R)-4-Fluoro-2-(6-(furan-2-yl)-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3-ol;9H-Purine, 9-(3-deoxy-3-fluoro-β-D-ribofuranosyl)-6-(2-furanyl)-;6-(Furan-2-yl)purine-beta-D-(3’-deoxy-3’-fluoro)riboside | | CAS: | 1612191-89-5 | | MF: | C14H13FN4O4 | | MW: | 320.28 | | EINECS: | | | Product Categories: | | | Mol File: | 1612191-89-5.mol |  |
| | 6-(Furan-2-yl)purine-beta-D-(3'-deoxy-3'-fluoro)riboside Chemical Properties |
| Boiling point | 616.6±65.0 °C(Predicted) | | density | 1.78±0.1 g/cm3(Predicted) | | pka | 12.45±0.70(Predicted) |
| | 6-(Furan-2-yl)purine-beta-D-(3'-deoxy-3'-fluoro)riboside Usage And Synthesis |
| Uses | 9-(3-Deoxy-3-fluoro-β-D-ribofuranosyl)-6-(furan-2-yl)purine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | | References | [1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
| | 6-(Furan-2-yl)purine-beta-D-(3'-deoxy-3'-fluoro)riboside Preparation Products And Raw materials |
|